Heart and metabolic health in silent pheochromocytoma or paraganglioma
Part of Brain & nervous system, Cancer, Genetic & congenital, Heart & circulation, Hormones & metabolism, Pain clinical trials.
This study looks at heart and metabolic health in people who have pheochromocytomas or paragangliomas that do not produce extra hormones. It aims to understand whether these 'silent' tumors affect cardiovascular and metabolic health, and how they compare to other cases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a pheochromocytoma or paraganglioma that is not causing any typical symptoms (like headaches or sweating).
- Your blood or urine tests for catecholamines and metanephrines are within the normal range — not elevated.
- Your diagnosis is confirmed either by a tissue sample (biopsy) or by special imaging such as MIBG or DOTATATE scans.
- You have available records of heart and metabolic test results from before or after any treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps doctors better understand and diagnose pheochromocytoma and paraganglioma—rare tumors that release stress hormones and cause high blood pressure and other symptoms. Researchers will study your medical history, blood and urine tests, imaging scans, and genetic information to improve how these conditions are found and understood.
This study looks at people who have been newly diagnosed with pheochromocytoma/paraganglioma (PPGL), those with a past history of PPGL, or those with genetic risk for it. It may help doctors better evaluate and understand PPGL using specific tests.
This study is collecting information from people with certain adrenal gland tumors (pheochromocytoma, paraganglioma, or adrenocortical tumor). It aims to learn more about these conditions, which may help improve future care. Both living and deceased patients can be included.
This study looks at how the immune system responds to rare adrenal or nerve-related tumors (pheochromocytoma and paraganglioma). Researchers want to understand the tumor's environment, which may help improve future treatments.
This study tests a special blood pressure monitoring system during surgery to remove a pheochromocytoma, a rare tumor that can cause dangerous blood pressure spikes. The system aims to help doctors keep your blood pressure stable during the operation.
This study looks at past patient data to find patterns that might predict whether a pheochromocytoma or paraganglioma (rare tumors of the adrenal glands or nerve tissue) will spread. It aims to create a tool to help doctors estimate risk and plan treatment.
Hear when a new Cardiovascular Abnormalities trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.